Over 40 years of fosmidomycin drug research: a comprehensive review and future opportunities

T Knak, MA Abdullaziz, S Höfmann, LA Alves Avelar… - Pharmaceuticals, 2022 - mdpi.com
To address the continued rise of multi-drug-resistant microorganisms, the development of
novel drugs with new modes of action is urgently required. While humans biosynthesize the …

Development of Inhibitors of the 2C-Methyl-d-erythritol 4-Phosphate (MEP) Pathway Enzymes as Potential Anti-Infective Agents

T Masini, AKH Hirsch - Journal of medicinal chemistry, 2014 - ACS Publications
Important pathogens such as Mycobacterium tuberculosis and Plasmodium falciparum, the
causative agents of tuberculosis and malaria, respectively, and plants, utilize the 2 C-methyl …

A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling

B Zhang, KM Watts, D Hodge, LM Kemp… - Biochemistry, 2011 - ACS Publications
Antimicrobial drug resistance is an urgent problem in the control and treatment of many of
the world's most serious infections, including Plasmodium falciparum malaria, tuberculosis …

Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparum

T Umeda, N Tanaka, Y Kusakabe, M Nakanishi… - Scientific Reports, 2011 - nature.com
The human malaria parasite Plasmodium falciparum is responsible for the deaths of more
than a million people each year. Fosmidomycin has been proven to be efficient in the …

Biochemistry of the non-mevalonate isoprenoid pathway

T Gräwert, M Groll, F Rohdich, A Bacher… - Cellular and molecular …, 2011 - Springer
The non-mevalonate pathway of isoprenoid (terpenoid) biosynthesis is essential in many
eubacteria including the major human pathogen, Mycobacterium tuberculosis, in …

[HTML][HTML] Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways

S Baumeister, J Wiesner, A Reichenberg, M Hintz… - PloS one, 2011 - journals.plos.org
Background Highly charged compounds typically suffer from low membrane permeability
and thus are generally regarded as sub-optimal drug candidates. Nonetheless, the highly …

Selection of an Aptamer against the Enzyme 1-deoxy-D-xylulose-5-phosphate Reductoisomerase from Plasmodium falciparum

C Roca, Y Avalos-Padilla, B Prieto-Simón, V Iglesias… - Pharmaceutics, 2022 - mdpi.com
The methyl erythritol phosphate (MEP) pathway of isoprenoid biosynthesis is essential for
malaria parasites and also for several human pathogenic bacteria, thus representing an …

Design, Synthesis, and X-ray Crystallographic Studies of α-Aryl Substituted Fosmidomycin Analogues as Inhibitors of Mycobacterium tuberculosis 1-Deoxy-d …

M Andaloussi, LM Henriksson… - Journal of medicinal …, 2011 - ACS Publications
The natural antibiotic fosmidomycin acts via inhibition of 1-deoxy-d-xylulose 5-phosphate
reductoisomerase (DXR), an essential enzyme in the non-mevalonate pathway of …

Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr): a review of the synthesis and biological evaluation of recent inhibitors

ER Jackson, CS Dowd - Current topics in medicinal chemistry, 2012 - ingentaconnect.com
Isoprene biosynthesis is an essential component of metabolism. Two pathways are known
for the production of five-carbon (isoprene) intermediates: the mevalonate and …

Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr)

CT Behrendt, A Kunfermann, V Illarionova… - Journal of medicinal …, 2011 - ACS Publications
Reverse hydroxamate-based inhibitors of IspC, a key enzyme of the non-mevalonate
pathway of isoprenoid biosynthesis and a validated antimalarial target, were synthesized …